Skip to content

Vital Sign Monitor Device Validation - WARD

Vital Sign Monitor Device Validation - WARD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06106516
Acronym
ViVa-WARD
Enrollment
1000
Registered
2023-10-30
Start date
2023-10-24
Completion date
2028-12-31
Last updated
2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Complication, Surgery-Complications

Brief summary

Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting. Patients: up to 1000 medical and/or surgical patients will be included Intervention: Studies with various wirless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device.

Detailed description

Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting. Patients: up to 1000 medical and/or surgical patients will be included. Intervention: Studies with various wireless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device. Other statistical assessments of agreement may be chosen as secondary outcomes, dependent on the data-structure Setting: the study will be carried out in up to 76 hours with collection of vital sign data pre-, intra or postoperatively.

Interventions

DEVICEnovel vital sign monitor

Devices that are to be introduced into the clinic but where data from clinical relevant conditions such as complications are lacking to assess the validity under clinical conditions

Sponsors

Bispebjerg Hospital
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

No inclusion or

Design outcomes

Primary

MeasureTime frameDescription
Agreement between vital sign data from novel device and golden standard76 hoursagreement between novel device and golden standard or clinical standard devices, assess by bias and limits of agreement

Secondary

MeasureTime frameDescription
Description of data from novel device and golden standard76 hoursdescriptive statistics using parametric or non-parametric statistics where appropriate

Countries

Denmark

Contacts

Primary ContactEske K Aasvang, DMSci
eske.kvanner.aasvang.01@regionh.dk+4526232076
Backup ContactChristian S Meyhoff, PhD
Christian.sylvest.meyhoff@regionh.dk+4524910542

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026